HMG-CoA Reductase Inhibitor [EPC]

328378 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	17560
1	NAUSEA	16493
2	DRUG INEFFECTIVE	16412
3	DYSPNOEA	15859
4	DIARRHOEA	14740
5	DIZZINESS	13892
6	ASTHENIA	11905
7	PAIN	11760
8	FALL	11473
9	HEADACHE	11042

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	IMMUNE-MEDIATED NECROTISING MYOPATHY	251	0.4547
1	IMMUNE-MEDIATED MYOSITIS	299	0.3833
2	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	241	0.2648
3	MYOPATHY	1681	0.2570
4	HYPERPARATHYROIDISM SECONDARY	541	0.2549
5	NEPHROGENIC ANAEMIA	958	0.2306
6	RHABDOMYOLYSIS	7049	0.2233
7	REBOUND ACID HYPERSECRETION	517	0.1787
8	SEDATION COMPLICATION	196	0.1569
9	POLYMYOSITIS	206	0.1483

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]